Anzeige
Mehr »
Login
Mittwoch, 12.05.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
Milliardär und "Starinvestor" verdoppelt jetzt seine Position in einem Pennystock
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DiAlvotech, not content to line up behind other Humira biosims, sues AbbVie over 'wrongful monopoly'
DiAstraZeneca shareholders approve CEO Soriot's contentious 2021 pay plan, defying wishes of 4 advisory groups
DiViatris, Organon could merge given similar business models, but one of them already seems more credible: analyst
Di2 ads for 2 audiences: SK Life targets docs and patients in seizure drug campaign
DiPfizer, Regeneron CEOs see extended need for COVID-19 vaccines, treatments as pandemic enters next phase
DiWith lower COVID-19 cases expected this summer, Eli Lilly to welcome all employees back to Indianapolis HQ
DiWith cost cuts and asset sales largely wrapped, Takeda gears up for growth: CEO
DiPharma putting digital drug delivery at heart of plans: survey
DiSiga seeks FDA approval for intravenous smallpox therapy
DiOliX allies with PCI to develop dermatological RNAi therapies
DiPfizer's COVID-19 vaccine scores FDA nod in adolescents, enabling a wider rollout
MoEli Lilly taps 3 Indian drugmakers to bolster supply of COVID-19 drug baricitinib
MoPharma industry's reputation hits plateau amid spike in vaccine hesitancy
MoWill a waiver work? Don't expect COVID-19 vaccine patents to lift quickly, if ever, analysts say
MoWith $15B COVID-19 vaccine sales in sight, BioNTech aspires to become a 'global immunotherapy powerhouse'
MoStryker takes a swing at ballpark joint-replacement promos with Minor League partnership
MoBioNTech, Fosun Pharma eye 1B doses of COVID-19 vaccine capacity with new China JV
SaNovo Nordisk recalls sales rep samples sunk by Texas power outages
FrPfizer, Merck KGaA's Bavencio hits NICE roadblock in bladder cancer coverage
FrEven with the pandemic in retreat, Amgen will let most employees keep working from home
FrPfizer, AstraZeneca COVID vaccines probed in Europe after reports of heart inflammation, rare nerve disorder
FrAstraZeneca's lagging I-O drug tremelimumab finally pulls through with Imfinzi combo score in lung cancer
FrAnother 5 years of dominance: Oncology, immunology will extend their lead as pharma's top fields through 2025
FrFierce Pharma Asia-BeiGene touts Q1, PARP inhibitor nod; Astellas culls muscle disease pact
DoCatalent snares yet another Belgian CDMO to boost fast-growing cell and gene therapy campus